X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4686) 4686
Publication (508) 508
Book Review (75) 75
Book Chapter (29) 29
Dissertation (16) 16
Conference Proceeding (3) 3
Book / eBook (2) 2
Magazine Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3015) 3015
humans (2830) 2830
oncology (2664) 2664
egfr (2069) 2069
mutation (1942) 1942
gefitinib (1854) 1854
lung cancer (1719) 1719
chemotherapy (1449) 1449
lung neoplasms - drug therapy (1363) 1363
female (1351) 1351
epidermal growth factor (1348) 1348
lung neoplasms - genetics (1333) 1333
cancer (1294) 1294
erlotinib (1252) 1252
male (1177) 1177
lung cancer, non-small cell (1158) 1158
carcinoma, non-small-cell lung - drug therapy (1125) 1125
receptor, epidermal growth factor - genetics (1058) 1058
middle aged (1040) 1040
carcinoma, non-small-cell lung - genetics (991) 991
aged (979) 979
lung neoplasms - pathology (953) 953
open-label (899) 899
acquired-resistance (872) 872
adenocarcinoma (869) 869
non-small cell lung cancer (862) 862
tyrosine kinase inhibitors (841) 841
growth-factor receptor (833) 833
protein kinase inhibitors - therapeutic use (828) 828
genetic aspects (791) 791
tyrosine (786) 786
receptor, epidermal growth factor - antagonists & inhibitors (755) 755
antineoplastic agents - therapeutic use (747) 747
care and treatment (744) 744
respiratory tract diseases (744) 744
adult (724) 724
kinases (712) 712
cell lung-cancer (694) 694
nsclc (681) 681
egfr mutation (676) 676
egfr mutations (668) 668
carcinoma, non-small-cell lung - pathology (667) 667
tumors (645) 645
1st-line treatment (641) 641
respiratory system (621) 621
analysis (611) 611
cancer therapies (603) 603
epidermal growth factor receptor (571) 571
tyrosine kinase inhibitor (563) 563
aged, 80 and over (560) 560
cell line, tumor (557) 557
metastasis (556) 556
research (547) 547
prognosis (530) 530
resistance (529) 529
animals (526) 526
epidermal growth factor receptors (502) 502
mutations (495) 495
quinazolines - therapeutic use (482) 482
patients (476) 476
health aspects (475) 475
hematology, oncology and palliative medicine (475) 475
receptor, epidermal growth factor - metabolism (472) 472
treatment outcome (467) 467
protein kinase inhibitors - pharmacology (466) 466
survival (458) 458
antineoplastic agents - pharmacology (456) 456
erbb receptors - genetics (446) 446
non-small cell lung carcinoma (406) 406
pharmacology & pharmacy (403) 403
therapy (403) 403
expression (391) 391
neoplasms. tumors. oncology. including cancer and carcinogens (373) 373
adenocarcinoma - genetics (371) 371
development and progression (371) 371
growth-factor-receptor (357) 357
medicine & public health (356) 356
drug resistance (350) 350
lung neoplasms - metabolism (349) 349
afatinib (343) 343
cell biology (341) 341
drug resistance, neoplasm (341) 341
protein-tyrosine kinase (341) 341
pulmonary/respiratory (334) 334
quinazolines - pharmacology (334) 334
medical prognosis (332) 332
gene mutations (325) 325
neoplasm staging (324) 324
lung neoplasms - mortality (322) 322
retrospective studies (315) 315
disease-free survival (314) 314
non-small-cell lung cancer (310) 310
studies (308) 308
targeted therapy (301) 301
erlotinib hydrochloride (300) 300
pathology (293) 293
apoptosis (292) 292
lung cancer, small cell (284) 284
drug therapy (282) 282
review (281) 281
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4645) 4645
Chinese (80) 80
Japanese (16) 16
French (9) 9
Korean (8) 8
German (5) 5
Polish (3) 3
Portuguese (2) 2
Russian (1) 1
Slovenian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Cancer, ISSN 0020-7136, 05/2019, Volume 144, Issue 10, pp. 2605 - 2612
Journal Article
Journal Article
Journal Article
International Journal of Cancer, ISSN 0020-7136, 01/2019, Volume 144, Issue 1, pp. 200 - 209
Journal Article
International journal of cancer, ISSN 0020-7136, 07/2019
The purpose of our study was to investigate time trends in treatment pattern and prognostic factors for overall survival (OS) in epidermal growth factor... 
time trends | Clinical Medicine | EGFR TKI | real word data | comorbidity | Medical and Health Sciences | Medicin och hälsovetenskap | nonsmall cell lung cancer | survival | Cancer and Oncology | Klinisk medicin | Cancer och onkologi
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 06/2011, Volume 6, Issue 6, pp. 1006 - 1015
Journal Article
Journal Article
MEDICINE, ISSN 0025-7974, 01/2018, Volume 97, Issue 1, p. e9021
Rationale: The mechanism of the first-generation epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) acquired resistance included T790M... 
lung cancer | CELL LUNG-CANCER | MEDICINE, GENERAL & INTERNAL | SPECIMENS | EGFR-TKIs | pleural effusion | acquired resistance | cellular-mesenchymal to epithelial transition factor amplification
Journal Article